Daiwa Securities Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-248
| Closed | – | – | 1279 |
|
|
2024
Q3 | $0 | Hold |
248
| – | – | ﹤0.01% | 1270 |
|
|
2024
Q2 | $0 | Hold |
248
| – | – | ﹤0.01% | 1304 |
|
|
2024
Q1 | $0 | Hold |
248
| – | – | ﹤0.01% | 1306 |
|
|
2023
Q4 | $0 | Hold |
248
| – | – | ﹤0.01% | 1309 |
|
|
2023
Q3 | $2K | Hold |
248
| – | – | ﹤0.01% | 1202 |
|
|
2023
Q2 | $3K | Hold |
248
| – | – | ﹤0.01% | 1201 |
|
|
2023
Q1 | $2K | Hold |
248
| – | – | ﹤0.01% | 1192 |
|
|
2022
Q4 | $4K | Hold |
248
| – | – | ﹤0.01% | 1155 |
|
|
2022
Q3 | $4K | Hold |
248
| – | – | ﹤0.01% | 1161 |
|
|
2022
Q2 | $3K | Buy |
248
+69
| +39% | +$835 | ﹤0.01% | 1185 |
|
|
2022
Q1 | $3K | Hold |
179
| – | – | ﹤0.01% | 1201 |
|
|
2021
Q4 | $3K | Buy |
+179
| New | +$3K | ﹤0.01% | 1225 |
|
|
2019
Q4 | – | Sell |
-170
| Closed | – | – | 1185 |
|
|
2019
Q3 | $0 | Hold |
170
| – | – | ﹤0.01% | 1163 |
|
|
2019
Q2 | $0 | Hold |
170
| – | – | ﹤0.01% | 1181 |
|
|
2019
Q1 | $1K | Hold |
170
| – | – | ﹤0.01% | 1141 |
|
|
2018
Q4 | $1K | Hold |
170
| – | – | ﹤0.01% | 1107 |
|
|
2018
Q3 | $2K | Hold |
170
| – | – | ﹤0.01% | 1103 |
|
|
2018
Q2 | $3K | Hold |
170
| – | – | ﹤0.01% | 1104 |
|
|
2018
Q1 | $3K | Buy |
+170
| New | +$3K | ﹤0.01% | 1089 |
|